Yung Zip Chemical Ind. Co., Ltd. (Taiwan, China)

In 1987, initially Yung Zip Chemical was founded for manufacturing and supplying the active pharmaceutical ingredients (APIs) to Yung Shin Pharma. (one of the leading pharmaceutical industries in Taiwan). Through years' researching and improving, Yung Zip Chemical had laid the groundwork for the technology and quality, also started expanding its business scope, Yung Zip started serving and supplying the APIs to other domestic pharmaceutical industries, and earned a foremost position in bulk pharmaceutical chemical industry in Taiwan. It was an important foundation for Yung Zip to step into international market and become an international company. In 2001, Yung Zip Chemical had been inspected, approved by US FDA and ensured our excellent quality, allowing its products to market in US, Europe and other industrialization countries. Yung Zip was approved IPO on July 2, 1997 and was officially listed in OTC on March 20, 2001. The company's product portfolio consists of diclofenac sodium (DCS), which is applied in treatment of rheumatoid arthritis, bursitis and inflammation; sodium starch glycolate (SSG), which is used as disintegrant in pharmaceutical preparation; mefenamic acid (MFA), which is applied in treatment of neuralgia, arthritis pain, dysmenorrhea and headache; acyclovir (ACV), which is utilized in treatment of herpesvirus infections, and miconazole nitrate (MCN), which is applied in treatment of yeast infection.